Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

@article{Colucci2000IntravenousNA,
  title={Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.},
  author={Wilson Steven Colucci and Uri Elkayam and Darlene P Horton and William T. Abraham and Robert C Bourge and Aaron D. Johnson and Lynne E. Wagoner and Michael M. Givertz and Chang Seng Liang and M T Neibaur and W. Herbert Haught and Thierry H Lejemtel},
  journal={The New England journal of medicine},
  year={2000},
  volume={343 4},
  pages={246-53}
}
BACKGROUND Intravenous infusion of nesiritide, a brain (B-type) natriuretic peptide, has beneficial hemodynamic effects in patients with decompensated congestive heart failure. We investigated the clinical use of nesiritide in such patients. METHODS Patients hospitalized because of symptomatic congestive heart failure were enrolled in either an efficacy trial or a comparative trial. In the efficacy trial, which required the placement of a Swan-Ganz catheter, 127 patients with a pulmonary… CONTINUE READING
Highly Influential
This paper has highly influenced 17 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 286 extracted citations

Similar Papers

Loading similar papers…